Home/Publication/Sherpa, CDH VGC Join Qiming to Treat Chronic Hep B Infection
Sherpa, CDH VGC Join Qiming to Treat Chronic Hep B Infection 

30 Dec 2024

US$ 19.00

Sherpa Healthcare Partners and CDH Venture and Growth Capital were party to the US$73 million series B funding round ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Granite Asia has appointed Ms Ming Eng as a partner, responsible for co-managing its credit solution offerings ......

Qiming Venture Partners (Qiming) has agreed to acquire a 26.1% stake in the Shenzhen-listed Zhengzhou Tiamaes ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.